• Citations Per Year
Learn More
PURPOSE To compare the safety and efficacy of a new enhanced viscosity ophthalmic formulation of tobramycin, given twice daily (BID), with the existing four times daily (QID) treatment regimen in patients with acute bacterial conjunctivitis. METHODS This was a 12-day, multicenter, observer-masked, randomized, parallel group study. Patients received one(More)
  • 1